Form 4: Plus Therapeutics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Marc H Hedrick, Chief Executive Officer and a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 6,387 Common Stock on October 1, 2026; holds 50,870 after (Direct).
- Option exercise/conversion: acquired 8,066 Common Stock on October 1, 2026; holds 58,936 after (Direct).
- Option exercise/conversion: acquired 1,986 Common Stock on October 1, 2026; holds 60,922 after (Direct).
- Option exercise/conversion: disposed of 6,387 Restricted Stock Units on October 1, 2026; holds 147,211 after (Direct).
- Option exercise/conversion: disposed of 8,066 Restricted Stock Units on October 1, 2026; holds 139,145 after (Direct).
- Option exercise/conversion: disposed of 1,986 Restricted Stock Units on October 1, 2026; holds 137,159 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Marc H Hedrick — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 6,387 | — | — | 50,870 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 8,066 | — | — | 58,936 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,986 | — | — | 60,922 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 6,387 | — | — | 147,211 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 8,066 | — | — | 139,145 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,986 | — | — | 137,159 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (6,387 shares) |
| 2026-10-01 | Option exercise/conversion (8,066 shares) |
| 2026-10-01 | Option exercise/conversion (1,986 shares) |
| 2026-10-01 | Option exercise/conversion (6,387 shares) |
| 2026-10-01 | Option exercise/conversion (8,066 shares) |
| 2026-10-01 | Option exercise/conversion (1,986 shares) |
Keywords
insider transaction, Form 4, CNSY, CERENOME, INC., neutral, Marc H Hedrick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.